 | |
 | |
| Names | |
|---|---|
| Preferred IUPAC name 2-(2,4,5-Trimethoxyphenyl)ethan-1-amine | |
| Other names 2C-O; 2C-OMe; 2,4,5-TMPEA; TMPEA-2 | |
| Identifiers | |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider |
|
| UNII | |
| |
| |
| Properties | |
| C11H17NO3 | |
| Molar mass | 211.261 g·mol−1 |
| Melting point | 187 to 188 °C (369 to 370 °F; 460 to 461 K) |
| Pharmacology | |
| Legal status | |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
2,4,5-Trimethoxyphenethylamine (2,4,5-TMPEA orTMPEA-2), also known as2C-O or2C-OMe, or is aphenethylamine of the2C family and was first synthesized by Jansen in 1931.[1] It is apositional isomer of the drugmescaline (3,4,5-trimethoxy).
2C-O is a member of a class ofchemical compounds commonly known asphenethylamines. Its full chemical name is 2-(2,4,5-trimethoxyphenyl)ethanamine; it is also known as 2,4,5-trimethoxyphenethylamine and 2,4,5-TMPEA.
Although not centrally active itself, 2C-O appeared to potentiate the action of mescaline when employed as pretreatment 45 minutes prior to the administration of mescaline.[2]
The toxicity of 2C-O is not known.
As of October 31, 2016, 2C-O is a controlled substance (Schedule III) in Canada.[3]
2C-O is aSchedule I substance, as a positional isomer ofmescaline.
2C-O and all other compounds featured inPiHKAL areClass A drugs in the United Kingdom.
